Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of fibrate treatment in dyslipidemia: an overview.

Current pharmaceutical design·2013

Same author

Ezetimibe therapy for dyslipidemia: an update.

Current pharmaceutical design·2013

Same author

Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.

Current pharmaceutical design·2013

Same author

PCSK9 inhibition - a novel mechanism to treat lipid disorders?

Current pharmaceutical design·2013

Same author

Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?

Current pharmaceutical design·2013

Same author

Achieving current goals in prevention and treatment of vascular disease: an update.

Current pharmaceutical design·2013

Search research articles

Related Experiment Video

Updated: Nov 7, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Endocan: a new marker of endothelial function.

Sevket Balta¹, Ilknur Balta², Dimitri P Mikhailidis^3,4

¹Department of Cardiology, Hayat Hospital, Malatya.

Current Opinion in Cardiology

|April 30, 2021

Summary

Endocan, an endothelial inflammatory marker, is linked to cardiovascular disease. This review explores its role in vascular inflammation and heart conditions.

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Related Experiment Videos

Last Updated: Nov 7, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Area of Science:

Cardiology
Vascular Biology
Inflammation Research

Background:

Vascular endothelial inflammation is central to cardiovascular disease pathogenesis.
It influences key processes like thrombogenesis and mediator secretion.
Endocan is an endothelial cell-derived inflammatory marker.

Purpose of the Study:

To review the role of endocan as an inflammatory marker in cardiovascular diseases.
To discuss endocan's significance in the context of cardiology.

Main Methods:

Literature review focusing on endocan and cardiovascular conditions.
Analysis of current research on endothelial inflammation markers.

Main Results:

Endocan is associated with cardiovascular disease.
It serves as a marker of endothelial inflammation.

Conclusions:

Endocan plays a significant role in the inflammatory processes underlying cardiovascular diseases.
Further investigation into endocan's clinical utility in cardiology is warranted.